Qualio provides a cloud-based electronic quality management system (eQMS) for teams launching and scaling life‑saving products across the life sciences ecosystem. Led by founder and CEO Robert Fenton, the platform helps pharmaceutical, biotech, medical device, and clinical research organizations unite processes and data to manage critical quality processes across their supply chains. The company reports more than 250 life sciences customers worldwide, including Medable, Paula’s Choice Skincare, Proscia, and Ginkgo Bioworks. Qualio intends to use the new funds to expand accessibility of its eQMS and services at global scale and to invest in product and engineering team growth. The article states the company has raised more than $63M to date. Qualio provides a cloud-based electronic quality management system (eQMS) purpose-built for medical devices, pharmaceuticals, biotech and contract service providers. Its software unites fragmented teams, tools, and data to simplify and automate critical quality processes and support FDA audits. The company emphasizes enabling Life Sciences organizations to grow through all 12 pillars of quality as they scale. Qualio is remote-first with a team distributed across North America and Europe. The company plans to scale its product and continue building its remote-first team using the proceeds of the Series A. The announcement highlights customer trust and the platform’s role in bringing life-saving products to market more quickly.

Total raised

$61M

Funding rounds

2

Latest round

Series B

Latest activity

May 2021